Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter

636 search results for ‘*’

Outside the Lab Policy

D is for Decolonize: Sitting Down With Luis Pizarro

| Angus Stewart | 10 min read

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world


Disease Area Cardiovascular

On Thin Eyes…

| Jed Boye | 2 min read

Researchers probe the relationship between cardiovascular risk factors and inner retinal thickness

Tools & Techniques Analytical science

The Truth’s in the Tooth

| James Strachan | 3 min read

Detecting biomarkers of fetal alcohol spectrum disorder in naturally shed baby teeth opens the door to diagnosis

Tools & Techniques Imaging

When You Hear Hooves

| Geoffrey Potjewyd

The sound of hooves doesn’t always equate to horses; untangling the overlap between Sjögren’s syndrome and dry eye may take some nerve (imaging)

Questioning “The Science”

| James Strachan | 2 min read

What would it mean for science as a whole if the results of a seminal Alzheimer's paper underpinning the amyloid hypothesis were fabricated?

Disease Area Neurological

From Viral Video to Magic Medicine

| Angus Stewart | 2 min read

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

Outside the Lab Professional development

Hurdles and High Jumps – Chapter 5: Investors Invest in People

| Rich Whitworth | 8 min read

How to sell your translational research project – and yourself

Research Field Neuroscience

Viewing the Inaccessible

| Geoffrey Potjewyd | 2 min read

The brain and cerebral vasculature are notoriously difficult to access – is OCT the key to the door?

Tools & Techniques Clinical trials

Insights Management: the Next Phase of Clinical R&D Gains

| Tony Page | 5 min read

Current approaches to R&D tech investment are not helping life science companies. How can the situation be improved?

Research Field Cell & gene therapy

Clearing Stress

| Michael R. Volkert | 5 min read

A gene therapy targeting a gene that regulates antioxidant action may effectively treat retinal degeneration

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register